Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
(6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Al-LAD is a semi-synthetic lysergamide and primarily acts as an agonist at the 5-HT2A receptor. It induces psychedelic effects that may include visual and cognitive changes. The substance is pharmacologically related to LSD but exhibits its own effect profile. Risks include psychological distress and potential cardiovascular effects.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Designations
IUPAC: (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Effects & Pharmacology is partially translated. Some content may appear in German.
Al-LAD primarily acts as an agonist at the 5-HT2A receptor, leading to the characteristic psychedelic effects. The substance affects serotonergic transmission in the brain and can induce visual as well as cognitive changes.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Total duration 8-12 hours
Peak
2-4 hours
Onset
30-60 minutes
Total duration
8-12 hours
After effects
1-3 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, and pre-existing conditions significantly affect outcomes.
Risks
Evidence
Begrenzte formale Humandaten. Tiermodelle und Erfahrungsberichte vorhanden. Rechtsstatus variiert — in mehreren Ländern als NPS reguliert.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
May interact with other serotonergic substances.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.